Catalyst Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CPRX

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. 

CEO
Richard John Daly
CEORichard John Daly
Employees
181
Employees181
Headquarters
Coral Gables, Florida
HeadquartersCoral Gables, Florida
Founded
2002
Founded2002
Employees
181
Employees181

CPRX Key Statistics

Market cap
2.57B
Market cap2.57B
Price-Earnings ratio
13.69
Price-Earnings ratio13.69
Dividend yield
—
Dividend yield—
Average volume
1.36M
Average volume1.36M
High today
$21.70
High today$21.70
Low today
$20.99
Low today$20.99
Open price
$21.64
Open price$21.64
Volume
1.18M
Volume1.18M
52 Week high
$26.58
52 Week high$26.58
52 Week low
$15.34
52 Week low$15.34

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CPRX. This list is generated using Robinhood data, and it’s not a recommendation.
OPKO Health
Viking Therapeutics
Assertio
Agenus
MiNK Therapeutics
SNDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.